Financhill
Back

Cartesian Therapeutics Quote, Financials, Valuation and Earnings

Cartesian Therapeutics Price Quote

$16.80
-0.14 (-0.83%)
(Updated: November 21, 2024 at 10:55 AM ET)

Cartesian Therapeutics Key Stats

Sell
26
Cartesian Therapeutics (RNAC) is a Sell

Day range:
$16.85 - $18.20
52-week range:
$11.67 - $42.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.45
P/B ratio:
627.6%

Volume:
114.4K
Avg. volume:
106.1K
1-year change:
-49.58%
Market cap:
$472M
Revenue:
$26M
EPS:
$-54.95

How Much Does Cartesian Therapeutics Make?

Is Cartesian Therapeutics Growing As A Company?

Cartesian Therapeutics Stock Price Performance

What Is Cartesian Therapeutics 52-Week High & Low?

Cartesian Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cartesian Therapeutics?

Is Cartesian Therapeutics Cash Flow Positive?

  • What Is RNAC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$40M
  • What Is Cartesian Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $181.7M
  • What Is Cartesian Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.9M

Cartesian Therapeutics Return On Invested Capital

Data Unavailable

Cartesian Therapeutics Earnings Date & Stock Price

Cartesian Therapeutics Competitors

Cartesian Therapeutics Dividend Yield

Cartesian Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 23.09%
Revenue: -94.09% -78.89%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 40.25
Upside from Last Price: 137.6%

Major Shareholders

  • How many RNAC shares are owned by institutional investors?
    20.9M RNAC shares are owned by institutional investors
  • How many RNAC shares are owned by insiders?
    19.5M RNAC shares are owned by insiders